Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in RET Fusion-Positive NSCLC
LIBRETTO-431 研究的患者报告结局:RET 融合阳性非小细胞肺癌一线治疗中,塞帕替尼与帕博利珠单抗联合化疗的比较
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2025.100814
Zhou, Caicun; Novello, Silvia; Garrido, Pilar; Dooms, Christophe; Alatorre-Alexander, Jorge; Reinmuth, Niels; Worthy, Gill; Cocks, Kim; Williams, Justin; Han, Hongmei; Uh, Minji K; Payakachat, Nalin; Gilligan, Adrienne M; Goto, Koichi